Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine

被引：18
|
作者：
Baldanti, F [1 ]
Paolucci, S
Maga, G
Labo, N
Hübscher, U
Skoblov, AY
Victorova, L
Spadari, S
Minoli, L
Gerna, G
机构：
[1] IRCCS, Policlin San Matteo, Serv Virol, Pavia, Italy
[2] CNR, Ist Genet Mol, Pavia, Italy
[3] Univ Zurich, Inst Vet Biochem & Mol Biol, Zurich, Switzerland
[4] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia
[5] Univ Pavia, Ist Clin Malattie Infett, Pavia, Italy
来源：
AIDS | 2003年 / 17卷 / 10期
关键词：
D O I：
10.1097/00002030-200307040-00021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Stavudine administration did not increase the frequency of Y181I/C reverse transcriptase (RT) mutations in non-nucleoside reverse transcriptase inhibitor (NNRTI)-treated patients. However, recombinant Y181C HIV-1 showed reduced stavudine susceptibility with respect to both recombinant wild-type and K103N HIV-1 strains. In addition, recombinant Y181I RT enzyme showed reduced susceptibility to stavudine with respect to both wild-type and K103N RT. A previously unnoticed role of Y181I/C RT changes selected by nevirapine or other NNRTI in determining stavudine resistance is documented.
引用
收藏
页码：1568 / 1570
页数：3
相关论文
共 50 条
  • [21] EFFECTS OF POINT MUTATIONS IN THE HIV-1 REVERSE-TRANSCRIPTASE NEVIRAPINE BINDING-SITE ON NEVIRAPINE BINDING AND TERTIARY STRUCTURE
    BACOLLA, A
    SHIH, CK
    ROSE, JM
    PIRAS, G
    WARREN, TC
    GRYGON, CA
    COUSINS, RC
    GREENWOOD, DJ
    INGRAHAM, RH
    GRIFFIN, J
    CHENG, YC
    BIOPHYSICAL JOURNAL, 1993, 64 (02) : A368 - A368
  • [22] The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages
    Archer, RH
    Wisniewski, M
    Bambara, RA
    Demeter, LM
    BIOCHEMISTRY, 2001, 40 (13) : 4087 - 4095
  • [23] Spectrum of HIV-1 reverse transcriptase mutations selected by nucleoside reverse transcriptase inhibitor treatment is greater than previously reported
    Gonzales, MJ
    Wu, T
    Taylor, J
    Belitskaya, I
    Kantor, R
    Israelski, D
    Chou, S
    Zolopa, AR
    Fessel, J
    Shafer, RW
    ANTIVIRAL THERAPY, 2002, 7 : S38 - S38
  • [24] HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors
    Fitzgibbon, JE
    DiCola, MB
    Arnold, E
    Das, K
    Sha, BE
    Pottage, JC
    Nahass, R
    Gaur, S
    John, JF
    ANTIVIRAL THERAPY, 2001, 6 (04) : 231 - 238
  • [25] N348I in HIV-1 Reverse Transcriptase Counteracts the Synergy Between Zidovudine and Nevirapine
    Yap, Soo Huey
    Herman, Brian D.
    Radzio, Jessica
    Sluis-Cremer, Nicolas
    Tachedjian, Gilda
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (02) : 153 - 157
  • [26] Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency
    Bollini, Mariela
    Gallardo-Macias, Ricardo
    Spasov, Krasimir A.
    Tirado-Rives, Julian
    Anderson, Karen S.
    Jorgensen, William L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (04) : 1110 - 1113
  • [27] HIV-1 reverse transcriptase M184V and R212 K combined mutations conconfer phenotypic resistance to stavudine
    Nicastri, E
    Sarmati, L
    Parisi, SG
    D'Ettorre, C
    Narciso, F
    Vullo, V
    Andreoni, M
    AIDS, 2000, 14 : S112 - S112
  • [28] Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors
    Clark, Shauna A.
    Shulman, Nancy S.
    Bosch, Ronald J.
    Mellors, John W.
    AIDS, 2006, 20 (07) : 981 - 984
  • [29] Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors
    Sugiura, W
    Matsuda, M
    Matsuda, Z
    Abumi, H
    Okano, A
    Oishi, T
    Moriya, K
    Yamamoto, T
    Fukutake, K
    Mimaya, J
    Ajisawa, A
    Taki, M
    Yamada, K
    Nagai, Y
    JOURNAL OF HUMAN VIROLOGY, 1999, 2 (03) : 146 - 153
  • [30] MUTATIONS IN THE C-TERMINAL REGION OF THE HIV-1 REVERSE TRANSCRIPTASE AND THEIR CORRELATION WITH DRUG RESISTANCE ASSOCIATED MUTATIONS AND ANTIVIRAL TREATMENT
    Michels, I.
    Staszewski, S.
    Guettler, L.
    Nisius, G.
    Mueller, A.
    Locher, L.
    Doerr, H. -W.
    Stuermer, M.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (10) : 415 - 421
12345